Enzon extends shareholder rights plan expiration to March 24, 2026 via Tenth Amendment

Viskase Holdings, Inc.

Tenth Amendment to Section 382 Rights Agreement extends Final Expiration Date from noon March 18 to noon March 24, 2026.
Rights Agreement otherwise remains unmodified; this is the tenth successive short-term extension since June 2024.
Company states extension is in best interests of Enzon and its stockholders.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Viskase Holdings, Inc. amended Tenth Amendment to Section 382 Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-03-18).

Action: amendment
Counterparty: Continental Stock Transfer & Trust Company
Effective: 2026-03-18

Exact text from the filing

On March 18, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Tenth Amendment to the Section 382 Rights Agreement (the “ Tenth Amendment ”)

View on SEC.gov

310 material agreements filed in the last 30 days. Browse all material agreements →

Viskase Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-029952

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.